Annukka Lehtonen1, Shruti Garg2, Stephen A Roberts3, Dorothy Trump, D Gareth Evans1, Jonathan Green2, Susan M Huson1. 1. Manchester Centre for Genomic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK. 2. Institute for Brain, Behaviour and Mental Health, University of Manchester, Manchester, UK. 3. Centre for Biostatistics, Institute of Population Health, University of Manchester, Manchester, UK.
Abstract
AIM: This study aimed to investigate the core cognitive deficits in children with neurofibromatosis type 1 (NF1). METHOD: The study recruited 49 children with NF1 (25 males, 24 females; mean age 11y 9mo [SD 3y 2mo]), 19 healthy siblings of children with NF1 (sibling comparisons; mean age 12y 7mo [SD 2y 7mo], 9 males, 10 females) and 29 healthy children from the community (community comparisons; mean age 11y [SD 2y 7mo], 12 males, 17 females). Participants completed a battery of cognitive tests including tests of intelligence, academic achievement, attention, visuoperceptual functioning, visual learning, executive functioning, and non-verbal working memory tests. RESULTS: Our study, using a population-based sample, confirmed previous findings from studies using variable sampling methods. Children with NF1 had significantly lower Full-scale IQs (p=0.04) and lower academic achievement (p=0.026-0.005) than their siblings. Compared with their siblings, they also had significantly poorer visuospatial processing (p=0.007), visual associate learning (p=0.014), non-verbal working memory (p=0.023), and executive function (p<0.001). Data from the community comparisons were not included because they were subject to significant selection bias. INTERPRETATION: Population-based frequencies for cognitive deficits in children with NF1 are similar to the frequencies in non-population based samples. This study highlights the heterogeneous nature of cognitive problems in children with NF1 and the need for monitoring and support at school.
AIM: This study aimed to investigate the core cognitive deficits in children with neurofibromatosis type 1 (NF1). METHOD: The study recruited 49 children with NF1 (25 males, 24 females; mean age 11y 9mo [SD 3y 2mo]), 19 healthy siblings of children with NF1 (sibling comparisons; mean age 12y 7mo [SD 2y 7mo], 9 males, 10 females) and 29 healthy children from the community (community comparisons; mean age 11y [SD 2y 7mo], 12 males, 17 females). Participants completed a battery of cognitive tests including tests of intelligence, academic achievement, attention, visuoperceptual functioning, visual learning, executive functioning, and non-verbal working memory tests. RESULTS: Our study, using a population-based sample, confirmed previous findings from studies using variable sampling methods. Children with NF1 had significantly lower Full-scale IQs (p=0.04) and lower academic achievement (p=0.026-0.005) than their siblings. Compared with their siblings, they also had significantly poorer visuospatial processing (p=0.007), visual associate learning (p=0.014), non-verbal working memory (p=0.023), and executive function (p<0.001). Data from the community comparisons were not included because they were subject to significant selection bias. INTERPRETATION: Population-based frequencies for cognitive deficits in children with NF1 are similar to the frequencies in non-population based samples. This study highlights the heterogeneous nature of cognitive problems in children with NF1 and the need for monitoring and support at school.
Authors: Matthew E Fasano-McCarron; Jane Holmes Bernstein; Deborah P Waber; Jane W Newburger; David R DeMaso; David C Bellinger; Adam R Cassidy Journal: J Int Neuropsychol Soc Date: 2021-01-14 Impact factor: 2.892
Authors: Andrew J D Crow; Jennica M Janssen; Carolina Marshall; Anne Moffit; Laura Brennan; Christian G Kohler; David R Roalf; Paul J Moberg Journal: Am J Med Genet A Date: 2022-05-12 Impact factor: 2.578
Authors: Cameron Sawyer; Jonathan Green; Ben Lim; Gorana Pobric; JeYoung Jung; Grace Vassallo; D Gareth Evans; Charlotte J Stagg; Laura M Parkes; Stavros Stivaros; Nils Muhlert; Shruti Garg Journal: Cereb Cortex Commun Date: 2022-05-19
Authors: Yang Hou; Taryn Allen; Pamela L Wolters; Mary Anne Toledo-Tamula; Staci Martin; Andrea Baldwin; Stephanie Reda; Andy Gillespie; Anne Goodwin; Brigitte C Widemann Journal: Dev Med Child Neurol Date: 2020-02-12 Impact factor: 4.864
Authors: Eve Lalancette; Audrey-Rose Charlebois-Poirier; Kristian Agbogba; Inga Sophia Knoth; Emily J H Jones; Luke Mason; Sébastien Perreault; Sarah Lippé Journal: J Neurodev Disord Date: 2022-07-22 Impact factor: 4.074
Authors: Anna May Kolesnik; Emily Jane Harrison Jones; Shruti Garg; Jonathan Green; Tony Charman; Mark Henry Johnson Journal: Mol Autism Date: 2017-11-23 Impact factor: 7.509
Authors: Gorana Pobric; Jason R Taylor; Hemavathy M Ramalingam; Emily Pye; Louise Robinson; Grace Vassallo; JeYoung Jung; Misty Bhandary; Karolina Szumanska-Ryt; Louise Theodosiou; D Gareth Evans; Judith Eelloo; Emma Burkitt-Wright; Johan Hulleman; Jonathan Green; Shruti Garg Journal: J Autism Dev Disord Date: 2021-05-08